Share Price:

APNASPENAspen Pharmacare Hldgs2193888 (0.40%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Aspen announces multi-territory acquisition of GSK OTC products for R2.1 billion

Aspen Pharmacare Holdings Limited (“Aspen”) (Incorporated in the Republic of South Africa) Registration Number 1985/002935/06 Share code APN – ISIN: ZAE000066692 (“Aspen Holdings”) ASPEN ANNOUNCES MULTI-TERRITORY ACQUISITION OF GSK OTC PRODUCTS FOR R2.1 BILLION Durban, South Africa: Aspen Holdings is pleased to announce that the Aspen Group (“Aspen”) has reached agreement with GlaxoSmithKline plc (“GSK”)… Continue reading Aspen announces multi-territory acquisition of GSK OTC products for R2.1 billion

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.